The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard

How Funding Cuts Left the World Vulnerable to Ebola
24:58

What Trump Delivered for Amazon
41:34

Been Sanctioned by the US Government? There’s a Guy for That
26:51